KIG
Kennedy Investment Group’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.81M | Sell |
15,139
-92
| -0.6% | -$17.1K | 1.19% | 22 |
|
2025
Q1 | $3.19M | Sell |
15,231
-169
| -1% | -$35.4K | 1.48% | 17 |
|
2024
Q4 | $2.74M | Buy |
15,400
+1,732
| +13% | +$308K | 1.24% | 18 |
|
2024
Q3 | $2.7M | Sell |
13,668
-43
| -0.3% | -$8.49K | 1.24% | 18 |
|
2024
Q2 | $2.35M | Buy |
13,711
+729
| +6% | +$125K | 1.19% | 22 |
|
2024
Q1 | $2.36M | Sell |
12,982
-934
| -7% | -$170K | 1.26% | 19 |
|
2023
Q4 | $2.16M | Buy |
13,916
+1,354
| +11% | +$210K | 1.21% | 23 |
|
2023
Q3 | $1.87M | Sell |
12,562
-673
| -5% | -$100K | 1.13% | 25 |
|
2023
Q2 | $1.78M | Sell |
13,235
-1,337
| -9% | -$180K | 1.04% | 27 |
|
2023
Q1 | $2.32M | Buy |
14,572
+79
| +0.5% | +$12.6K | 1.42% | 21 |
|
2022
Q4 | $2.34M | Buy |
+14,493
| New | +$2.34M | 1.49% | 20 |
|